At NeonMind Biosciences, we believe in “mind over matter”. We plan to help people change their lives by changing their minds, through treatment with psychedelics.

The power to change your mind

Our first step is tackling one of the biggest health issues the world is facing right now: obesity. It’s an epidemic that is responsible for 37% of the global burden of disease. We know that being overweight puts people at risk for development of a number of chronic diseases; cardiovascular disease, diabetes, osteoarthritis, and some types of cancer. We also understand that it’s not an easy issue for people to fix on their own. Traditional weight loss methods don’t work for everyone, and often don’t address the mental health issues that are sometimes tied to obesity.

Obesity accounts for
37%
of the global burden of disease.

NeonMind is exploring psilocybin (a complex organic compound found in psychedelic mushrooms) as an innovative treatment approach to weight loss through a preclinical trial. We know that psilocybin is known to activate serotonin receptors, and that serotonin can curb cravings, shut off appetite, and reduce eating. We’ve hired the University of British Columbia to conduct our Preclinical Trial, exploring the potential therapeutic use of psilocybin to improve eating habits and cause weight loss.

The landscape is rapidly changing when it comes to the use of psychedelics for medical treatments. There is a major shift on the horizon and we believe in the potential for psychedelics to revolutionize the way we treat issues around mental health and obesity. 

psilocybin based treatments

Obesity Epidemic

Obesity is the cause behind many diseases and other health problems and has been formally recognized by the World Health Organization as a global epidemic:

  • 2.8 million people die each year as a result of being overweight or obese; and
  • In 2016, more than 1.9 billion adults, 18 years and older, were overweight.

Preclinical and Clinical Trials

Our preclinical trial is designed to gather information about our psilocybin based drug treatment to help with weight loss and treat obesity and related illnesses.

  • We are working with the University of British Columbia to carry out our preclinical research.   
  • The principal investigator of our preclinical trial is Dr. Alasdair Barr, Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine at the University of British Columbia.
  • We have signed a restricted drug supply agreement with Psygen Labs Inc. for psilocybin supply through an agent for our preclinical trial, direct supply for our potential clinical trials, and for potential commercial launch of a drug product to aid weight loss.
  • On October 7, 2020, Health Canada granted approval to Dr. Alasdair Barr to possess psilocybin to carry out our preclinical trial, and the trial officially started in November 2020.
  • We expect to have enough information from our preclinical trial to apply for our planned Phase 2 Human Clinical Trial in the Spring of 2021.
  • We have filed 5 U.S. provisional patents to protect our intellectual property related to the administration of psychedelic substances to aid in weight loss, treat obesity and its complications, reduce food cravings, treat compulsive eating disorders and alter the diets of individuals.

Medicinal Mushrooms

The Opportunity

While psychedelic drugs and treatments are still in their infancy, there is a large immediate opportunity in medicinal mushroom products. NeonMind is using its proprietary formulations and expertise to generate near term and long term revenue.

The global market for functional mushrooms is forecasted to reach $34.3 billion by 2024.

NeonMind has manufactured a collection of 4 quality, flavorful mushroom infused coffees as our initial market entry. Our products are infused with legal medicinal mushrooms such as Lion’s Mane, Turkey Tail, Reishi and Cordyceps.

Mushroom coffees appeal to a growing market as physical and mental wellness (also referred to as self care) has become a focus for people. One in four U.S. adults wants to try medicinal mushrooms to help manage their overall health and wellness.

1 in 4 U.S. adults wants to try medicinal mushrooms.

Mushroom Infused Coffees

Our NeonMind mushroom infused coffee eCommerce platform launched in November 2020 at www.neonmind.com for direct to consumer sales of these products.

Try all our coffees
4 Blends Ritual
Instant Coffees
Rest Blend

A well-balanced coffee infused with Lion’s Mane and Reishi mushrooms, as well as Ashwagandha and Turmeric.

Buy Now
Energize Blend

Robust coffee infused with Turkey Tail and Cordycep mushrooms, blended with Holy Basil and Moringa.

Buy Now
Brewed Coffees
Protect Blend(Medium Roast)

A robust coffee infused with Turkey Tail and Cordycep mushrooms, blended with Moringa and Amla Berry.

Buy Now
Focus Blend(Dark Roast)

A well-balanced coffee infused with Lion’s Mane and Reishi mushrooms, combined with Gotu Kola and Brahmi.

Buy Now

Our Formula Catalog

We hold the global rights to a robust catalog of more than 145 product formulations for infusion with functional mushrooms to promote health and wellness.